Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
2021 · Arthritis & Rheumatology · 153 citations
https://doi.org/10.1002/art.41943
E
Ettore Silvagni
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
1.6K
Citations
22
h-index
40
i10-index
Ettore Silvagni is an academic researcher from University of Ferrara. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & Rheumatoid Arthritis Research and Therapies & Spondyloarthritis Studies and Treatments. The author has an h-index of 22, co-authored 82 publications.
ORCID: 0000-0001-7654-8222Papers by this author
worksPragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
2024 · Annals of the Rheumatic Diseases · 27 citations
https://doi.org/10.1136/ard-2023-224919
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions
2021 · Brain Sciences · 8 citations
https://doi.org/10.3390/brainsci12010070
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study
2026 · The Lancet Rheumatology · 0 citations
https://doi.org/10.1016/s2665-9913(25)00316-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat